Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer	Metastatic Castration-Resistant Prostate Cancer	Active, not recruiting	Phase 2	2026-06-22		NCT04419402

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Astellas Pharma Inc	43
Australian and New Zealand Urogenital and Prostate Cancer Trials Group	10
Endocyte	3
National Health and Medical Research Council, Clinical Trials Centre	1
Prostate Cancer Research Alliance	2

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Health	Heidelberg	Australia	70
Calvary Mater Newcastle	Newcastle	Australia	8
Chris O'Brien Lifehouse	Camperdown	Australia	46
Fiona Stanley Hospital	Perth	Australia	16
Liverpool Hospital	Liverpool	Australia	66
Macquarie University Hospital	Macquarie Park	Australia	10
Monash Health	Clayton	Australia	74
Northern Cancer Institute	Sydney	Australia	2
Peter MacCallum Cancer Centre	Melbourne	Australia	3
Royal Adelaide Hospital	Adelaide	Australia	132
Royal Brisbane and Women's Hospital	Brisbane	Australia	23
Sir Charles Gairdner Hospital	Nedlands	Australia	43
St George Hospital	Kogarah	Australia	21
St Vincents Hospital	Darlinghurst	Australia	2
The Alfred Hospital	Melbourne	Australia	110